In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $1.53 down -3.16% from its previous closing price of $1.58. In other words, the price has decreased by -$3.16 from its previous closing price. On the day, 1.92 million shares were traded. TSHA stock price reached its highest trading level at $1.615 during the session, while it also had its lowest trading level at $1.51.
Ratios:
For a deeper understanding of Taysha Gene Therapies Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.51. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 313562784 and an Enterprise Value of 312804800. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.64 while its Price-to-Book (P/B) ratio in mrq is 3.53. Its current Enterprise Value per Revenue stands at 31.549 whereas that against EBITDA is -3.854.
Stock Price History:
The Beta on a monthly basis for TSHA is 0.93, which has changed by 0.026845694 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -26.31%, while the 200-Day Moving Average is calculated to be -34.94%.
Shares Statistics:
For the past three months, TSHA has traded an average of 4.49M shares per day and 2337870 over the past ten days. A total of 204.94M shares are outstanding, with a floating share count of 153.61M. Insiders hold about 25.05% of the company’s shares, while institutions hold 69.37% stake in the company. Shares short for TSHA as of 1735603200 were 25878980 with a Short Ratio of 5.76, compared to 1732838400 on 15670007. Therefore, it implies a Short% of Shares Outstanding of 25878980 and a Short% of Float of 16.66.
